Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis Interventions: Drug: Rebamipide; Drug: Nanoparticulated Rebamipide; Drug: Clobetasol Propionate Sponsor: Cairo University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | Clobetasol | Methotrexate | Nanotechnology | Research | Rheumatoid Arthritis | Rheumatology